Skip to main content
. 2018 Jan 23;14(4):931–940. doi: 10.1080/21645515.2017.1420446

Figure 6.

Figure 6.

Therapeutic immunization with CpG and Poly I:C-adjuvanted vaccines induced potent tumor-specific IFN-γ expressing lymphocytes. (A) Representative ELISPOT picture. (B) E744-62-specific IFN-γ-expressing lymphocytes detected by ELISPOT. One-way ANOVA followed by Tukey's multiple comparisons test, *P<0.05, **P<0.01, n = 5 per group.